Citigroup Inc
NYSE : C$124.26+1.22%Oct 16 close
Financials
CONSOLIDATED BALANCE SHEET
USD · reported units. Click a value to inspect its source.
| Reported line item | Jun 30, 2026 (current) | Dec 31, 2025 |
|---|---|---|
| Statement of Financial Position [Abstract] | ||
| Statement [Table] | ||
| Financing Receivable Portfolio Segment [Axis] | ||
| Financing Receivable Portfolio Segment [Domain] | ||
| Consumer loans | ||
| Corporate loans | ||
| Statement [Line Items] | ||
| Assets | ||
| Cash and due from banks (including segregated cash and other deposits) | ||
| Deposits with banks, net of allowance | ||
| Securities borrowed and purchased under agreements to resell (including $214,711 and $206,110 as of June 30, 2026 and December 31, 2025, respectively, at fair value), net of allowance | ||
| Brokerage receivables, net of allowance | ||
| Trading account assets (including $283,649 and $228,816 pledged to creditors as of June 30, 2026 and December 31, 2025, respectively) | ||
| Investments: | ||
| Available-for-sale debt securities (including $7,136 and $4,931 pledged to creditors as of June 30, 2026 and December 31, 2025, respectively) | ||
| Held-to-maturity debt securities, net of allowance (fair value of which is $157,524 and $179,520 as of June 30, 2026 and December 31, 2025, respectively) (includes $125 and $70 pledged to creditors as of June 30, 2026 and December 31, 2025, respectively) | ||
| Equity securities (including $538 and $921 as of June 30, 2026 and December 31, 2025, respectively, at fair value) | ||
| Total investments | ||
| Loans: | ||
| Loans, net of unearned income | ||
| Allowance for credit losses on loans (ACLL) | ||
| Total loans, net | ||
| Goodwill | ||
| Intangible assets (including MSRs of $788 and $759 as of June 30, 2026 and December 31, 2025, respectively) | ||
| Premises and equipment, net of depreciation and amortization | ||
| Other assets (including $16,460 and $15,840 as of June 30, 2026 and December 31, 2025, respectively, at fair value), net of allowance | ||
| Total assets | ||
| Liabilities | ||
| Deposits (including $4,873 and $4,222 as of June 30, 2026 and December 31, 2025, respectively, at fair value) | ||
| Securities loaned and sold under agreements to repurchase (including $150,621 and $199,422 as of June 30, 2026 and December 31, 2025, respectively, at fair value) | ||
| Brokerage payables (including $3,210 and $5,492 as of June 30, 2026 and December 31, 2025, respectively, at fair value) | ||
| Trading account liabilities | ||
| Short-term borrowings (including $27,017 and $21,567 as of June 30, 2026 and December 31, 2025, respectively, at fair value) | ||
| Long-term debt (including $143,494 and $130,726 as of June 30, 2026 and December 31, 2025, respectively, at fair value) | ||
| Other liabilities, plus allowances | ||
| Total liabilities | ||
| Stockholders’ equity | ||
| Preferred stock ($1.00 par value; authorized shares: 30 million), issued shares: as of June 30, 2026—782,000 and as of December 31, 2025—802,000, at aggregate liquidation value | ||
| Common stock ($0.01 par value; authorized shares: 6 billion), issued shares: as of June 30, 2026—3,099,786,399 and as of December 31, 2025—3,099,752,593 | ||
| Additional paid-in capital | ||
| Retained earnings | ||
| Treasury stock, at cost: June 30, 2026—1,422,349,616 shares and December 31, 2025— 1,352,205,592 shares | ||
| Accumulated other comprehensive income (loss) (AOCI) | ||
| Total Citigroup stockholders’ equity | ||
| Noncontrolling interests—equity (NCI—equity) | ||
| Total equity | ||
| Total liabilities and equity |
35 line items · 2 reported periodsOriginal filing order · parentheses indicate negative amounts
Each column reflects this filing’s presentation. Original line items and period dates are preserved.